Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy.
Saved in:
| Title: | Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy. |
|---|---|
| Authors: | Iskierka-Jażdżewska, Elżbieta1 (AUTHOR) elaiskierka@gmail.com, Kim, Won Seog2,3 (AUTHOR), Cho, Seok-Goo4 (AUTHOR), Kim, Tae Min5 (AUTHOR), Jarque, Isidro6 (AUTHOR), Robak, Tadeusz1 (AUTHOR), Poon, Michelle7 (AUTHOR), Prince, H. Miles8 (AUTHOR), Oh, Sung Yong9 (AUTHOR), Lim, Francesca10 (AUTHOR), Carpio, Cecilia11 (AUTHOR), Tan, Tran-Der12 (AUTHOR), Ayyappan, Sabarish13 (AUTHOR), Gutierrez, Antonio14 (AUTHOR), Zhang, Huilai15 (AUTHOR), Cao, Junning16 (AUTHOR), Tessoulin, Benoit17 (AUTHOR), Li, Jingjin18 (AUTHOR), Ivanescu, Cristina19 (AUTHOR), Reaney, Matthew20 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2025, Vol. 66 Issue 12, p2214-2225. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
